These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1620827)

  • 21. MR diagnosis of paraganglioma of the head and neck: value of contrast enhancement.
    van Gils AP; van den Berg R; Falke TH; Bloem JL; Prins HJ; Dillon EH; van der Mey AG; Pauwels EK
    AJR Am J Roentgenol; 1994 Jan; 162(1):147-53. PubMed ID: 8273654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary experience with gadolinium-enhanced dynamic MR imaging for uterine neoplasms.
    Hirano Y; Kubo K; Hirai Y; Okada S; Yamada K; Sawano S; Yamashita T; Hiramatsu Y
    Radiographics; 1992 Mar; 12(2):243-56. PubMed ID: 1561414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance arthrography of the scapulohumeral joint in dogs, using gadopentetate dimeglumine.
    van Bree H; Van Ryssen B; Degryse H; Ramon F
    Am J Vet Res; 1995 Mar; 56(3):286-8. PubMed ID: 7771693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain mapping with functional MR imaging: comparison of gradient-echo--based exogenous and endogenous contrast techniques.
    Mattay VS; Weinberger DR; Barrios FA; Sobering GS; Kotrla KJ; van Gelderen P; Duyn JH; Sexton RH; Moonen CT; Frank JA
    Radiology; 1995 Mar; 194(3):687-91. PubMed ID: 7862963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity.
    Kopka L; Funke M; Fischer U; Keating D; Oestmann J; Grabbe E
    AJR Am J Roentgenol; 1994 Sep; 163(3):621-3. PubMed ID: 8079856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the prostate and prostatic carcinoma with gadolinium-enhanced endorectal coil MR imaging.
    Mirowitz SA; Brown JJ; Heiken JP
    Radiology; 1993 Jan; 186(1):153-7. PubMed ID: 8416557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MR imaging of the brain in patients with AIDS: value of routine use of i.v. gadopentetate dimeglumine.
    Jensen MC; Brant-Zawadzki M
    AJR Am J Roentgenol; 1993 Jan; 160(1):153-7. PubMed ID: 8416615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gadolinium-enhanced MR imaging of the spleen: artifacts and potential pitfalls.
    Ito K; Mitchell DG; Honjo K; Fujita T; Awaya H; Takano K; Koike S; Matsumoto T; Matsunaga N
    AJR Am J Roentgenol; 1996 Nov; 167(5):1147-51. PubMed ID: 8911169
    [No Abstract]   [Full Text] [Related]  

  • 29. Gadopentetate dimeglumine-enhanced MR imaging of the musculoskeletal system.
    Beltran J; Chandnani V; McGhee RA; Kursunoglu-Brahme S
    AJR Am J Roentgenol; 1991 Mar; 156(3):457-66. PubMed ID: 1899738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cranial tissues: appearance at gadolinium-enhanced and nonenhanced MR imaging with magnetization transfer contrast.
    Elster AD; King JC; Mathews VP; Hamilton CA
    Radiology; 1994 Feb; 190(2):541-6. PubMed ID: 8284413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrast-enhanced MR Angiography of the renal arteries: blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
    Prokop M; Schneider G; Vanzulli A; Goyen M; Ruehm SG; Douek P; Daprà M; Pirovano G; Kirchin MA; Spinazzi A
    Radiology; 2005 Feb; 234(2):399-408. PubMed ID: 15616119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gadopentetate dimeglumine as an alternative contrast material for use in angiography.
    Kinno Y; Odagiri K; Andoh K; Itoh Y; Tarao K
    AJR Am J Roentgenol; 1993 Jun; 160(6):1293-4. PubMed ID: 8388622
    [No Abstract]   [Full Text] [Related]  

  • 33. Is it necessary to routinely use gadolinium in the MR imaging evaluation of soft-tissue tumors of the extremities?
    Kransdorf MJ
    AJR Am J Roentgenol; 1995 Dec; 165(6):1545. PubMed ID: 7484606
    [No Abstract]   [Full Text] [Related]  

  • 34. Cartilaginous tumors: correlation of gadolinium-enhanced MR imaging and histopathologic findings.
    Geirnaerdt MJ; Bloem JL; Eulderink F; Hogendoorn PC; Taminiau AH
    Radiology; 1993 Mar; 186(3):813-7. PubMed ID: 8430192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging.
    Peterson MS; Baron RL; Murakami T
    Radiology; 1996 Nov; 201(2):337-45. PubMed ID: 8888220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gadopentetate dimeglumine-enhanced MR imaging of the postoperative lumbar spine: comparison of fat-suppressed and conventional T1-weighted images.
    Mirowitz SA; Shady KL
    AJR Am J Roentgenol; 1992 Aug; 159(2):385-9. PubMed ID: 1632362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MR imaging of the normal meninges: comparison of contrast-enhancement patterns on 3D gradient-echo and spin-echo images.
    Farn JW; Mirowitz SA
    AJR Am J Roentgenol; 1994 Jan; 162(1):131-5. PubMed ID: 8273651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MR diagnosis of head and neck tumors: comparison of contrast enhancement with triple-dose gadodiamide and standard-dose gadopentetate dimeglumine in the same patients.
    Vogl TJ; Mack MG; Juergens M; Stark M; Pegios W; Bergman C; Grevers G; Western A
    AJR Am J Roentgenol; 1994 Aug; 163(2):425-32. PubMed ID: 8037044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrast-enhanced echo-planar MR imaging of myocardial perfusion: preliminary study in humans.
    Edelman RR; Li W
    Radiology; 1994 Mar; 190(3):771-7. PubMed ID: 8115626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hilar cholangiocarcinomas: T2-weighted spin-echo and gadolinium-enhanced FLASH MR imaging.
    Guthrie JA; Ward J; Robinson PJ
    Radiology; 1996 Nov; 201(2):347-51. PubMed ID: 8888221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.